UK MHRA Finds Labs Releasing Unreliable Data Due To Pressure From Pharma
Executive Summary
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.
You may also be interested in...
UK Explains Dos and Don’ts Of Adaptive Clinical Trials
Adaptive clinical trials offer several benefits, but they require effective management to be successful, says a senior inspector at the UK’s medicines regulator.
Canada Boosts Postmarket Device Safety With New Reporting Rules
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.
Global Regulators Seek Unified Approach To Remote Inspections
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: